Patten & Patten Inc. TN Cuts Stock Holdings in SPDR S&P Biotech ETF (NYSEARCA:XBI)

Patten & Patten Inc. TN reduced its position in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) by 6.0% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 6,155 shares of the exchange traded fund’s stock after selling 390 shares during the period. Patten & Patten Inc. TN’s holdings in SPDR S&P Biotech ETF were worth $554,000 at the end of the most recent quarter.

Several other large investors also recently bought and sold shares of the company. Addison Advisors LLC increased its stake in SPDR S&P Biotech ETF by 27.4% during the 4th quarter. Addison Advisors LLC now owns 535 shares of the exchange traded fund’s stock worth $48,000 after buying an additional 115 shares in the last quarter. Signature Estate & Investment Advisors LLC increased its stake in SPDR S&P Biotech ETF by 5.7% during the 3rd quarter. Signature Estate & Investment Advisors LLC now owns 2,336 shares of the exchange traded fund’s stock worth $231,000 after buying an additional 125 shares in the last quarter. Zurcher Kantonalbank Zurich Cantonalbank increased its stake in SPDR S&P Biotech ETF by 0.6% during the 3rd quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 23,873 shares of the exchange traded fund’s stock worth $2,373,000 after buying an additional 148 shares in the last quarter. Invst LLC increased its stake in SPDR S&P Biotech ETF by 6.0% during the 3rd quarter. Invst LLC now owns 2,807 shares of the exchange traded fund’s stock worth $277,000 after buying an additional 160 shares in the last quarter. Finally, Beech Hill Advisors Inc. increased its stake in SPDR S&P Biotech ETF by 2.5% during the 4th quarter. Beech Hill Advisors Inc. now owns 6,655 shares of the exchange traded fund’s stock worth $599,000 after buying an additional 162 shares in the last quarter.

SPDR S&P Biotech ETF Price Performance

XBI stock opened at $87.13 on Monday. The business has a 50 day simple moving average of $90.06 and a 200-day simple moving average of $94.78. The firm has a market capitalization of $5.65 billion, a PE ratio of 11.47 and a beta of 0.99. SPDR S&P Biotech ETF has a 1 year low of $81.14 and a 1 year high of $105.47.

SPDR S&P Biotech ETF Company Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.